| Regulation of the chemokine receptor CXCR4 by hypoxia | Journal of Experimental Medicine | 2003 | 695 |
| Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids | Journal of Experimental Medicine | 2003 | 640 |
| Strategic Survey of Therapeutic Drugs in the Rivers Po and Lambro in Northern Italy | Environmental Science & Technology | 2003 | 516 |
| Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis | Journal of Experimental Medicine | 2003 | 439 |
| Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148 | Journal of Cell Biology | 2003 | 340 |
| Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial | Diabetes Care | 2003 | 328 |
| Biochemical and functional characterization of the interaction between pentraxin 3 and C1q | European Journal of Immunology | 2003 | 279 |
| The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility | Journal of Cell Biology | 2003 | 276 |
| Familial haemolytic uraemic syndrome and an MCP mutation | Lancet, The | 2003 | 268 |
| Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease | Human Molecular Genetics | 2003 | 260 |
| The JAM family of junctional adhesion molecules | Current Opinion in Cell Biology | 2003 | 251 |
| Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial | Intensive Care Medicine | 2003 | 249 |
| Epidemiology and aetiology of gestational trophoblastic diseases | Lancet Oncology, The | 2003 | 243 |
| Redox proteomics: identification of oxidatively modified proteins | Proteomics | 2003 | 226 |
| Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation | Cancer Research | 2003 | 220 |
| Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development | Neurobiology of Disease | 2003 | 201 |
| ER-to-Golgi carriers arise through direct en bloc protrusion and multistage maturation of specialized ER exit domains | Developmental Cell | 2003 | 201 |
| European Code Against Cancer and scientific justification: third version (2003) | Annals of Oncology | 2003 | 197 |
| Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology | Biochemical Journal | 2003 | 194 |
| Retarding progression of chronic renal disease: the neglected issue of residual proteinuria | Kidney International | 2003 | 187 |
| Rituximab in idiopathic membranous nephropathy: a one-year prospective study | Journal of the American Society of Nephrology: JASN | 2003 | 169 |
| Dynamin participates in focal extracellular matrix degradation by invasive cells | Molecular Biology of the Cell | 2003 | 168 |
| Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat | Journal of the American Society of Nephrology: JASN | 2003 | 160 |
| Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis | CNS and Neurological Disorders | 2003 | 160 |
| Mechanism of constitutive export from the golgi: bulk flow via the formation, protrusion, and en bloc cleavage of large trans-golgi network tubular domains | Molecular Biology of the Cell | 2003 | 159 |
